ITRAQ-based proteomics analysis of tanshinone IIA on human ectopic endometrial stromal cells of adenomyosis
Proteomics analysis of tanshinone IIA on human ectopic endometrial stromal cells revealed 267 differential proteins, implicating focal adhesion, ECM-receptor, and estrogen signaling pathways in the drug's inhibitory effects.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (42)
- Adjuvant therapy of Chinese herbal medicine for the treatment of adenomyosis via openalex
- Comparative proteomic analysis of human adenomyosis using two-dimensional gel electrophoresis and mass spectrometry via openalex
- Conservative surgical treatment of adenomyosis to improve fertility: Controversial values, indications, complications, and pregnancy outcomes via openalex
- Evaluation of novel serum biomarkers and the proteomic differences of endometriosis and adenomyosis using MALDI-TOF–MS via openalex
- MRI for adenomyosis: a pictorial review via openalex
- Pathogenesis and malignant transformation of adenomyosis (Review) via openalex
- Pathogenesis of adenomyosis: an update on molecular mechanisms via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- [Progress on medical treatment in the management of adenomyosis]. via openalex
- Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review via openalex
- Serum differential proteomic analysis of endometriosis and adenomyosis by iTRAQ technique via openalex
- Surgery in adenomyosis via openalex
- Tanshinone IIA contributes to the pathogenesis of endometriosis via renin angiotensin system by regulating the dorsal root ganglion axon sprouting via openalex
- Tanshinone IIA inhibits the proliferation, migration and invasion of ectopic endometrial stromal cells of adenomyosis via 14-3-3ζ downregulation via openalex
- Uterine adenomyosis and adenomyoma: the surgical approach via openalex
- W2782061553 via openalex
- W2799452674 via openalex
- W2811054692 via openalex
- W2896737957 via openalex
- W2916298628 via openalex
- W2938801784 via openalex
- W2949433482 via openalex
- W2954366821 via openalex
- W2965649585 via openalex
- W2970489971 via openalex
- W2983644103 via openalex
- W2995769057 via openalex
- W2980556725 via openalex
- W1965498876 via openalex
- W1971308414 via openalex
- W1986262959 via openalex
- W2037199116 via openalex
- W2082981417 via openalex
- W2168270559 via openalex
- W2200906614 via openalex
- W2217692751 via openalex
- W2321570512 via openalex
- W2403260690 via openalex
- W2550361437 via openalex
- W2568898976 via openalex
- W2742440932 via openalex
- W2781934183 via openalex
Cited by (4)
- Tanshinone ⅡA participates in the treatment of endometriosis by regulating adhesion, invasion, angiogenesis and inhibition of PI3K/Akt/mTOR signaling pathway 2023
- Effect of Co-Cultured Bone Marrow Mesenchymal Stem Cells (BMSC) and Neuropilin 1 on the Migration of Endometrial Stromal Cells and Epithelial-Mesenchymal Transition in Adenomyosis 2022
- <i>In Vitro</i> Inhibitory Effects of Maqian Essential Oil against Ectopic Endometrial Stromal Cells and LPS‐Induced Endometrial Epithelial Cells 2022
- Exploration of the Modulatory Property Mechanism of ELeng Capsule in the Treatment of Endometriosis Using Transcriptomics Combined With Systems Network Pharmacology 2021
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:24:55.077982+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00